Starting May 1, the groundbreaking cystic fibrosis medication, Trikafta, will be accessible to Australian children aged 6-11 through the Pharmaceutical Benefits Scheme (PBS).

Mornings with Mark Levy - Full Show 23rd March
1:50:23

Mornings with Mark Levy - Full Show 20th March
1:56:42

'Quite surreal' - Outgoing NSW Ambulance Commissioner looks back on 40 years of service
14:45